Skip to content
★ Sign in to follow
RC

Rose C. Perri

Generex Biotechnology Corp
Total declarations
9
Company
1
▲ Purchases (4 ops.)
€20k
▼ Sales (3 ops.)
€9,202

Latest filing published 11 May 2011 for GENEREX BIOTECHNOLOGY CORP, €2,400.

Insider track record

Disclosed buys
4
Disclosed sells
3
Signal history

No signal scores available.

Closed purchases

Market purchases
4

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Rose C. Perri: trading record in brief

Rose C. Perri is a declared insider of Generex Biotechnology Corp, with filings sourced from SEC (Form 4). Between 17 August 2007 and 9 May 2011, the trades on record add up to 9 filings.

The open-market side counts 4 purchases for €20k alongside 3 sales for €9,202. Taken together, the purchases exceed the sales by €11k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 share grant and 1 option exercise. In 2011 alone, the filings show no purchases and 3 sales.

The median purchase comes to €2,936.

On 11 May 2011 came the latest disclosure, an open-market sale for €2,400 in Generex Biotechnology Corp. The most recent open-market purchase was published on 27 October 2010, 5,856 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Rose C. Perri

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total

9 of 9 declarations